RS
CVS icon

Rakuten Securities’s CVS Health CVS Stock Holding History

Rakuten Securities’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.9K Sell
28
-55
-66% -$4.91K ﹤0.01% 614
2026
Q1 		$5.96K Sell
83
-19
-19% -$1.46K ﹤0.01% 481
2025
Q4 		$8.1K Buy
102
+30
+42% +$2.37K ﹤0.01% 457
2025
Q3 		$5.43K Buy
72
+18
+33% +$1.23K ﹤0.01% 503
2025
Q2 		$3.73K Sell
54
-269
-83% -$17.6K ﹤0.01% 521
2025
Q1 		$21.9K Buy
323
+135
+72% +$8.08K 0.01% 305
2024
Q4 		$8.44K Buy
188
+145
+337% +$8.13K ﹤0.01% 414
2024
Q3 		$2.7K Buy
43
+11
+34% +$642 ﹤0.01% 486
2024
Q2 		$1.89K Sell
32
-26
-45% -$1.63K ﹤0.01% 494
2024
Q1 		$4.63K Buy
58
+7
+14% +$535 ﹤0.01% 408
2023
Q4 		$4.03K Buy
+51
New +$3.63K ﹤0.01% 370

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Rakuten Securities's CVS Position: Q2 2026 in Review

Rakuten Securities reduced its CVS Health (CVS) stake by 66% in Q2 2026, selling an estimated $4.91K and leaving 28 shares worth $2.9K. The position accounts for ﹤0.01% of the portfolio, ranked #614.

Rakuten Securities first reported a position in CVS in Q4 2023 and has held it in 11 quarters since. The position peaked at $21.9K in Q1 2025. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Rakuten Securities held 28 shares of CVS Health worth $2.9K as of Q2 2026.
  • Rakuten Securities sold 55 CVS Health shares in Q2 2026, an estimated $4.91K.
  • CVS Health made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #614 holding.
  • Rakuten Securities first reported a position in CVS Health in Q4 2023 and has held it in 11 quarters since.
  • Rakuten Securities's CVS Health position peaked at $21.9K in Q1 2025.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.